India's largest drugmaker Sun Pharmaceuticals on Tuesday announced a distribution agreement with Japan-based Mitsubishi Tanabe Pharma to market 14 prescription brands it acquired in Japan. Sun Pharma will aim to expand its sales channels in Japan while ensuring a steady supply of healthcare information, it stated. Notably, Japan is the world's second-largest pharmaceuticals market after the US.